Longitudinal Outcomes Following Surgical Repair of Primary Mitral Regurgitation.
Yuan QiuHiroki TakayaKay MaedaDavid Messika-ZeitounMarc RuelThierry MesanaVincent ChanPublished in: Journal of cardiovascular development and disease (2023)
Degenerative mitral valve (MV) disease is the most common cause of organic mitral regurgitation (MR) in developed countries. Surgical mitral valve repair is the gold standard treatment for primary MR. Surgical mitral valve repair is associated with excellent outcomes in terms of survival and freedom from recurrent MR. As well, innovations in surgical repair techniques, including thoracoscopically and robotically assisted approaches, further reduce morbidity. Emerging catheter-based therapies may also provide advantages in select patient groups. Although the outcomes following surgical mitral valve repair are well described in the literature, longitudinal follow-up is heterogenous. Indeed, longitudinal follow-up and long-term data are vital to better advise treatment and counsel patients.
Keyphrases
- mitral valve
- case report
- magnetic resonance
- systematic review
- end stage renal disease
- chronic kidney disease
- contrast enhanced
- cross sectional
- computed tomography
- type diabetes
- skeletal muscle
- combination therapy
- insulin resistance
- left ventricular
- atrial fibrillation
- big data
- adipose tissue
- smoking cessation
- patient reported
- silver nanoparticles
- artificial intelligence